https://doi.org/10.4081/ltj.2022.302

Happy news and sad news

Vol. 29 No. 2 (2022)
Published: 27 December 2022
Editorial, Laser Therapy
Abstract Views: 1449
PDF: 65
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Toshio Ohshiro
Founding Editor-in-Chief, Laser Therapy, Japan.

It is an honour and a pleasure to be writing this Guest Editorial for our journal, Laser Therapy, after 3 years of enforced silence because of what my colleague and friend Glen Calderhead calls Covidiocy. We were forced to shut down the Tokyo Editorial Office when Japan went into lockdown in 2019, and suspend publication of the journal, so my Glad News is that Laser Therapy has once again risen like the Phoenix, but this time it’s as an “e-Phoenix” and an e-Journal!

I am sure I am speaking for all Laser Therapy readers when I express my sincere gratitude to Professor Leonardo Longo of Florence, Italy, Secretary-General of the World Federation of Societies for Laser Medicine and Surgery (WFSLMS), who has been instrumental in securing a publisher for the re-emergence of the journal in an electronic digital format. Faithful readers will remember from my Editorials in the previous iteration of the journal that we were examining the possibility of moving over from a print version to a digital version, and now thanks to Prof Longo, that goal has been realised. [...]

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

How to Cite

Ohshiro, T. (2022). Happy news and sad news. Laser Therapy, 29(2). https://doi.org/10.4081/ltj.2022.302
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.